BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 26/08/2025

FDA Clears Heparin Sodium Products for Approval via Abbreviated New Drug Applications

The FDA has determined that four Heparin Sodium products were not withdrawn from sale due to safety or effectiveness concerns, paving the way for their approval through abbreviated new drug applications.

Source: Federal Register — Food and Drug AdministrationOpen original release →